Literature DB >> 6934375

Friend leukaemia virus-transformed cells, unlike normal stem cells, form spleen colonies in Sl/sld mice.

D Mager, T W Mak, A Bernstein.   

Abstract

Neoplastic cells are characterized by partial or total autonomy from the interactions that regulate the behaviour of normal cells in the intact animal. Despite the role of the host cellular environment in governing the proliferation and differentiation of both normal and malignant cells, little is known about these host factors. The characterization of host genes that influence both normal cellular processes, as well as susceptibility to tumour induction, is one approach to identifying such factors. Mice carrying two recessive mutations at the steel (Sl) locus have an environmental defect that affects both normal haematopoietic stem cell function as well as susceptibility to Friend leukaemia virus. In this study, we have used Sl/sld mice to examine whether malignant transformation by this RNA tumour virus results in a population of cells capable of proliferating even in the defective cellular microenvironment of Sl/sld mice. We report here that late after infection, the leukaemic spleens of Friend virus-infected mice contain cells which, unlike normal haematopoietic stem cells, are able to form macroscopic spleen colonies in irradiated mice of genotype Sl/Sld. This observation forms the basis for the first in vivo colony assay for leukaemic cells transformed by Friend virus.

Entities:  

Mesh:

Year:  1980        PMID: 6934375     DOI: 10.1038/288592a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  18 in total

1.  Clonal analysis of the late stages of erythroleukemia induced by two distinct strains of Friend leukemia virus.

Authors:  D Mager; M E MacDonald; I B Robson; T W Mak; A Bernstein
Journal:  Mol Cell Biol       Date:  1981-08       Impact factor: 4.272

2.  A common site for immortalizing proviral integrations in Friend erythroleukemia: molecular cloning and characterization.

Authors:  R Paul; S Schuetze; S L Kozak; D Kabat
Journal:  J Virol       Date:  1989-11       Impact factor: 5.103

3.  Natural killer cell suppression of Friend virus-induced preleukemic hemopoietic stem cells.

Authors:  R J Eckner; M Bennett; K L Hettrick; C Seidler
Journal:  J Virol       Date:  1987-08       Impact factor: 5.103

4.  Regulation of p53-mediated apoptosis and cell cycle arrest by Steel factor.

Authors:  J L Abrahamson; J M Lee; A Bernstein
Journal:  Mol Cell Biol       Date:  1995-12       Impact factor: 4.272

5.  Quantitative colony method for tumorigenic cells transformed by two distinct strains of Friend leukemia virus.

Authors:  D L Mager; T W Mak; A Bernstein
Journal:  Proc Natl Acad Sci U S A       Date:  1981-03       Impact factor: 11.205

6.  Isolation and induction of erythroleukemic cell lines with properties of erythroid progenitor burst-forming cell (BFU-E) and erythroid precursor cell (CFU-E).

Authors:  T Shibuya; T W Mak
Journal:  Proc Natl Acad Sci U S A       Date:  1983-06       Impact factor: 11.205

7.  A weakly pathogenic Rauscher spleen focus-forming virus mutant that lacks the carboxyl-terminal membrane anchor of its envelope glycoprotein.

Authors:  C A Machida; R K Bestwick; D Kabat
Journal:  J Virol       Date:  1985-03       Impact factor: 5.103

8.  Molecular cloning of biologically active Rauscher spleen focus-forming virus and the sequences of its env gene and long terminal repeat.

Authors:  R K Bestwick; B A Boswell; D Kabat
Journal:  J Virol       Date:  1984-09       Impact factor: 5.103

9.  Differentiation arrest and stromal cell-independent growth of murine erythroleukemia cells are associated with elevated expression of ets-related genes but not with mutation of p53.

Authors:  R J Nibbs; K Itoh; W Ostertag; P R Harrison
Journal:  Mol Cell Biol       Date:  1993-09       Impact factor: 4.272

10.  Multistage Friend erythroleukemia: independent origin of tumor clones with normal or rearranged p53 cellular oncogenes.

Authors:  V Chow; Y Ben-David; A Bernstein; S Benchimol; M Mowat
Journal:  J Virol       Date:  1987-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.